Mucosal immunity to poliovirus

Expert Review of Vaccines

Volumn 10, Issue 10, 2011, Pages 1389-1392

  Ogra, Pearay L ^a   Okayasu, Hiromasa ^b   Czerkinsky, Cecil ^c   Sutter, Roland W ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HOST FACTOR; IMMUNOGLOBULIN A; INTERLEUKIN 12; LRP1B PROTEIN; MATERNAL ANTIBODY; NECTIN 1; NECTIN 2; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BREAST FEEDING; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIARRHEA; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EPITHELIUM CELL; ERADICATION THERAPY; GENETIC POLYMORPHISM; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INDIA; INFECTION CONTROL; INNATE IMMUNITY; INOCULATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MUCOSAL IMMUNITY; NASOPHARYNX; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RETINOL DEFICIENCY; SEROCONVERSION; TROPISM; VACCINE FAILURE; VIROGENESIS; VIRUS ENTRY; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ZINC DEFICIENCY;

HUMANS; IMMUNITY, MUCOSAL; POLIOMYELITIS; POLIOVIRUS;

EID: 80053949404     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.106     Document Type: Conference Paper

References (14)

1. Grassly NC, Jafari H, Bahl S et al. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J. Infect. Dis. 201, 1535-1543 (2010).
2. Bodian D. Emerging concept of poliomyelitis infection. Science 122, 105-108 (1955).
3. Ghendon YZ, Sanakoyeva II. Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strains) in person after naturally and experimentally acquired immunity. Acta Virol. 5, 265-273 (1961).
4. Henry JL, Jaikaran ES, Davies JR et al. A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living polio vaccine. J. Hyg. 6, 105-120 (1966).
5. Fox JP, Gelfand HM, LeBlanc DR, Rowan DF. The influence of natural and artificially induced immunity on alimentary infections with polioviruses. Am. J. Public Health 9, 1181-1192 (1958).
6. Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhanced potency IPV and OPV. J. Infect. Dis. 163, 1-6 (1991).
7. Marine WM, Chin TD, Gravelle CR. Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children: a family study during a type 1 poliomyelitis epidemic. Am. J. Hyg. 76, 173-195 (1962).
8. The Cuba IPV Study Collaborative Group. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N. Engl. J. Med. 356, 1536-1544 (2007).
9. Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J. Infect. Dis. 162, 1291-1297 (1990).
10. Böttiger M. Polio immunity to killed vaccine: an 18-year follow up. Vaccine 8, 443-445 (1990).
11. Vekemans J, Ota MO, Wang EC et al. T cell responses to vaccines in infants: defective IFN gamma production after oral polio vaccination. Clin. Exp. Immunol. 127, 495-498 (2002).
12. Klein NP, Gans HA, Sung P et al. Preterm infants' T cell responses to inactivated poliovirus vaccine. J. Infect. Dis. 201, 214-222 (2010).
13. Honda K, Takeda K. Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunol. 2, 187-195 (2009).
14. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. J. Infect. Dis. 171, 1097-1106 (1995).